-
1
-
-
14944385553
-
Global cancer statistics, 2002
-
PMID: 15761078
-
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108 [PMID: 15761078]
-
(2005)
CA Cancer J Clin
, vol.55
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
Pisani, P.4
-
2
-
-
34547143659
-
Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis
-
945.e1-4 [PMID: 17509946
-
Ioannou GN, Splan MF, Weiss NS, McDonald GB, Beretta L, Lee SP. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 2007; 5: 938-45, 945.e1-4 [PMID: 17509946 DOI: 10.1016/j.cgh.2007.02.039]
-
(2007)
Clin Gastroenterol Hepatol
, vol.5
, pp. 938-945
-
-
Ioannou, G.N.1
Splan, M.F.2
Weiss, N.S.3
McDonald, G.B.4
Beretta, L.5
Lee, S.P.6
-
3
-
-
33745559765
-
The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients
-
PMID: 16729298
-
Sangiovanni A, Prati GM, Fasani P, Ronchi G, Romeo R, Manini M, Del Ninno E, Morabito A, Colombo M. The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients. Hepatology 2006; 43: 1303-1310 [PMID: 16729298 DOI: 10.1002/hep.21176]
-
(2006)
Hepatology
, vol.43
, pp. 1303-1310
-
-
Sangiovanni, A.1
Prati, G.M.2
Fasani, P.3
Ronchi, G.4
Romeo, R.5
Manini, M.6
Del Ninno, E.7
Morabito, A.8
Colombo, M.9
-
4
-
-
0032742183
-
Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation
-
PMID: 10573522
-
Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30: 1434-1440 [PMID: 10573522 DOI: 10.1002/hep.510300629]
-
(1999)
Hepatology
, vol.30
, pp. 1434-1440
-
-
Llovet, J.M.1
Fuster, J.2
Bruix, J.3
-
5
-
-
0033498334
-
An analysis of 412 cases of hepatocellular carcinoma at a Western center
-
discussion 799-800, PMID: 10363892
-
Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999; 229: 790-79; discussion 799-800 [PMID: 10363892]
-
(1999)
Ann Surg
, vol.229
, pp. 790-879
-
-
Fong, Y.1
Sun, R.L.2
Jarnagin, W.3
Blumgart, L.H.4
-
6
-
-
0032879468
-
Prognosis of hepatocellular carcinoma: The BCLC staging classification
-
PMID: 10518312
-
Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19: 329-338 [PMID: 10518312 DOI: 10.1055/s-2007-1007122]
-
(1999)
Semin Liver Dis
, vol.19
, pp. 329-338
-
-
Llovet, J.M.1
Brú, C.2
Bruix, J.3
-
7
-
-
44449085884
-
Design and endpoints of clinical trials in hepatocellular carcinoma
-
PMID: 18477802
-
Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M, Talwalkar J, Gores GJ. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 2008; 100: 698-711 [PMID: 18477802 DOI: 10.1093/jnci/djn134]
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 698-711
-
-
Llovet, J.M.1
Di Bisceglie, A.M.2
Bruix, J.3
Kramer, B.S.4
Lencioni, R.5
Zhu, A.X.6
Sherman, M.7
Schwartz, M.8
Lotze, M.9
Talwalkar, J.10
Gores, G.J.11
-
8
-
-
33644909117
-
Prospective validation of the Barcelona Clinic Liver Cancer staging system
-
PMID: 16488051
-
Cillo U, Vitale A, Grigoletto F, Farinati F, Brolese A, Zanus G, Neri D, Boccagni P, Srsen N, D'Amico F, Ciarleglio FA, Bridda A, D'Amico DF. Prospective validation of the Barcelona Clinic Liver Cancer staging system. J Hepatol 2006; 44: 723-731 [PMID: 16488051 DOI: 10.1016/j.jhep.2005.12.015]
-
(2006)
J Hepatol
, vol.44
, pp. 723-731
-
-
Cillo, U.1
Vitale, A.2
Grigoletto, F.3
Farinati, F.4
Brolese, A.5
Zanus, G.6
Neri, D.7
Boccagni, P.8
Srsen, N.9
D'amico, F.10
Ciarleglio, F.A.11
Bridda, A.12
D'amico, D.F.13
-
9
-
-
77950616983
-
A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma
-
PMID: 20112254
-
Cabibbo G, Enea M, Attanasio M, Bruix J, Craxì A, Cammà C. A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatology 2010; 51: 1274-1283 [PMID: 20112254 DOI: 10.1002/hep.23485]
-
(2010)
Hepatology
, vol.51
, pp. 1274-1283
-
-
Cabibbo, G.1
Enea, M.2
Attanasio, M.3
Bruix, J.4
Craxì, A.5
Cammà, C.6
-
10
-
-
0033922244
-
Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection
-
PMID: 10898182
-
Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 2000; 191: 38-46 [PMID: 10898182]
-
(2000)
J Am Coll Surg
, vol.191
, pp. 38-46
-
-
Belghiti, J.1
Hiramatsu, K.2
Benoist, S.3
Massault, P.4
Sauvanet, A.5
Farges, O.6
-
11
-
-
1242352399
-
The surgical approach to HCC: Our progress and results in Japan
-
PMID: 14762839
-
Makuuchi M, Sano K. The surgical approach to HCC: our progress and results in Japan. Liver Transpl 2004; 10: S46-S52 [PMID: 14762839 DOI: 10.1002/lt.20044]
-
(2004)
Liver Transpl
, vol.10
, pp. S46-S52
-
-
Makuuchi, M.1
Sano, K.2
-
12
-
-
33846463379
-
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
-
PMID: 17187432
-
Boyault S, Rickman DS, de Reyniès A, Balabaud C, Rebouissou S, Jeannot E, Hérault A, Saric J, Belghiti J, Franco D, Bioulac-Sage P, Laurent-Puig P, Zucman-Rossi J. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 2007; 45: 42-52 [PMID: 17187432 DOI: 10.1002/hep.21467]
-
(2007)
Hepatology
, vol.45
, pp. 42-52
-
-
Boyault, S.1
Rickman, D.S.2
De Reyniès, A.3
Balabaud, C.4
Rebouissou, S.5
Jeannot, E.6
Hérault, A.7
Saric, J.8
Belghiti, J.9
Franco, D.10
Bioulac-Sage, P.11
Laurent-Puig, P.12
Zucman-Rossi, J.13
-
13
-
-
57349090407
-
Gene expression in fixed tissues and outcome in hepatocellular carcinoma
-
PMID: 18923165
-
Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, Reich M, Chan JA, Glickman JN, Ikeda K, Hashimoto M, Watanabe G, Daidone MG, Roayaie S, Schwartz M, Thung S, Salvesen HB, Gabriel S, Mazzaferro V, Bruix J, Friedman SL, Kumada H, Llovet JM, Golub TR. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 2008; 359: 1995-2004 [PMID: 18923165 DOI: 10.1056/NEJMoa0804525]
-
(2008)
N Engl J Med
, vol.359
, pp. 1995-2004
-
-
Hoshida, Y.1
Villanueva, A.2
Kobayashi, M.3
Peix, J.4
Chiang, D.Y.5
Camargo, A.6
Gupta, S.7
Moore, J.8
Wrobel, M.J.9
Lerner, J.10
Reich, M.11
Chan, J.A.12
Glickman, J.N.13
Ikeda, K.14
Hashimoto, M.15
Watanabe, G.16
Daidone, M.G.17
Roayaie, S.18
Schwartz, M.19
Thung, S.20
Salvesen, H.B.21
Gabriel, S.22
Mazzaferro, V.23
Bruix, J.24
Friedman, S.L.25
Kumada, H.26
Llovet, J.M.27
Golub, T.R.28
more..
-
14
-
-
53049086329
-
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma
-
PMID: 18701503
-
Chiang DY, Villanueva A, Hoshida Y, Peix J, Newell P, Min-guez B, LeBlanc AC, Donovan DJ, Thung SN, Solé M, Tovar V, Alsinet C, Ramos AH, Barretina J, Roayaie S, Schwartz M, Waxman S, Bruix J, Mazzaferro V, Ligon AH, Najfeld V, Friedman SL, Sellers WR, Meyerson M, Llovet JM. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res 2008; 68: 6779-6788 [PMID: 18701503 DOI: 10.1158/0008-5472.CAN-08-0742]
-
(2008)
Cancer Res
, vol.68
, pp. 6779-6788
-
-
Chiang, D.Y.1
Villanueva, A.2
Hoshida, Y.3
Peix, J.4
Newell, P.5
Min-Guez, B.6
Leblanc, A.C.7
Donovan, D.J.8
Thung, S.N.9
Solé, M.10
Tovar, V.11
Alsinet, C.12
Ramos, A.H.13
Barretina, J.14
Roayaie, S.15
Schwartz, M.16
Waxman, S.17
Bruix, J.18
Mazzaferro, V.19
Ligon, A.H.20
Najfeld, V.21
Friedman, S.L.22
Sellers, W.R.23
Meyerson, M.24
Llovet, J.M.25
more..
-
15
-
-
0141491273
-
Hepatocellular carcinoma
-
PMID: 14667750
-
Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917 [PMID: 14667750 DOI: 10.1016/S0140-6736(03)14964-1]
-
(2003)
Lancet
, vol.362
, pp. 1907-1917
-
-
Llovet, J.M.1
Burroughs, A.2
Bruix, J.3
-
16
-
-
84858658381
-
EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma
-
European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. PMID: 22424438
-
European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-943 [PMID: 22424438 DOI: 10.1016/j.jhep.2011.12.001]
-
(2012)
J Hepatol
, vol.56
, pp. 908-943
-
-
-
17
-
-
84876143986
-
Resection of hepatocellular cancer ≤2 cm: Results from two Western centers
-
PMID: 22576353
-
Roayaie S, Obeidat K, Sposito C, Mariani L, Bhoori S, Pellegrinelli A, Labow D, Llovet JM, Schwartz M, Mazzaferro V. Resection of hepatocellular cancer ≤2 cm: results from two Western centers. Hepatology 2013; 57: 1426-1435 [PMID: 22576353 DOI: 10.1002/hep.25832]
-
(2013)
Hepatology
, vol.57
, pp. 1426-1435
-
-
Roayaie, S.1
Obeidat, K.2
Sposito, C.3
Mariani, L.4
Bhoori, S.5
Pellegrinelli, A.6
Labow, D.7
Llovet, J.M.8
Schwartz, M.9
Mazzaferro, V.10
-
18
-
-
0345299824
-
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
-
PMID: 8594428
-
Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699 [PMID: 8594428 DOI: 10.1056/NEJM199603143341104]
-
(1996)
N Engl J Med
, vol.334
, pp. 693-699
-
-
Mazzaferro, V.1
Regalia, E.2
Doci, R.3
Andreola, S.4
Pulvirenti, A.5
Bozzetti, F.6
Montalto, F.7
Ammatuna, M.8
Morabito, A.9
Gennari, L.10
-
19
-
-
0034991518
-
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
-
PMID: 11391528
-
Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403 [PMID: 11391528 DOI: 10.1053/jhep.2001.24563]
-
(2001)
Hepatology
, vol.33
, pp. 1394-1403
-
-
Yao, F.Y.1
Ferrell, L.2
Bass, N.M.3
Watson, J.J.4
Bacchetti, P.5
Venook, A.6
Ascher, N.L.7
Roberts, J.P.8
-
20
-
-
0036202371
-
Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters
-
PMID: 11923610
-
Roayaie S, Frischer JS, Emre SH, Fishbein TM, Sheiner PA, Sung M, Miller CM, Schwartz ME. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 2002; 235: 533-539 [PMID: 11923610]
-
(2002)
Ann Surg
, vol.235
, pp. 533-539
-
-
Roayaie, S.1
Frischer, J.S.2
Emre, S.H.3
Fishbein, T.M.4
Sheiner, P.A.5
Sung, M.6
Miller, C.M.7
Schwartz, M.E.8
-
21
-
-
57749191711
-
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: A retrospective, exploratory analysis
-
PMID: 19058754
-
Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL, Adam R, Neuhaus P, Salizzoni M, Bruix J, Forner A, De Carlis L, Cillo U, Burroughs AK, Troisi R, Rossi M, Gerunda GE, Lerut J, Belghiti J, Boin I, Gugenheim J, Rochling F, Van Hoek B, Majno P. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009; 10: 35-43 [PMID: 19058754 DOI: 10.1016/S1470-2045(08)70284-5]
-
(2009)
Lancet Oncol
, vol.10
, pp. 35-43
-
-
Mazzaferro, V.1
Llovet, J.M.2
Miceli, R.3
Bhoori, S.4
Schiavo, M.5
Mariani, L.6
Camerini, T.7
Roayaie, S.8
Schwartz, M.E.9
Grazi, G.L.10
Adam, R.11
Neuhaus, P.12
Salizzoni, M.13
Bruix, J.14
Forner, A.15
De Carlis, L.16
Cillo, U.17
Burroughs, A.K.18
Troisi, R.19
Rossi, M.20
Gerunda, G.E.21
Lerut, J.22
Belghiti, J.23
Boin, I.24
Gugenheim, J.25
Rochling, F.26
Van Hoek, B.27
Majno, P.28
more..
-
22
-
-
9744265831
-
Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma
-
PMID: 15565564
-
Sala M, Llovet JM, Vilana R, Bianchi L, Solé M, Ayuso C, Brú C, Bruix J. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004; 40: 1352-1360 [PMID: 15565564 DOI: 10.1002/hep.20465]
-
(2004)
Hepatology
, vol.40
, pp. 1352-1360
-
-
Sala, M.1
Llovet, J.M.2
Vilana, R.3
Bianchi, L.4
Solé, M.5
Ayuso, C.6
Brú, C.7
Bruix, J.8
-
23
-
-
3042658706
-
Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver
-
PMID: 15213625
-
Vivarelli M, Guglielmi A, Ruzzenente A, Cucchetti A, Bellusci R, Cordiano C, Cavallari A. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004; 240: 102-107 [PMID: 15213625]
-
(2004)
Ann Surg
, vol.240
, pp. 102-107
-
-
Vivarelli, M.1
Guglielmi, A.2
Ruzzenente, A.3
Cucchetti, A.4
Bellusci, R.5
Cordiano, C.6
Cavallari, A.7
-
24
-
-
33644662778
-
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma
-
PMID: 16495695
-
Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, Lin XJ, Lau WY. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243: 321-328 [PMID: 16495695 DOI: 10.1097/01. sla.0000201480.65519.b8]
-
(2006)
Ann Surg
, vol.243
, pp. 321-328
-
-
Chen, M.S.1
Li, J.Q.2
Zheng, Y.3
Guo, R.P.4
Liang, H.H.5
Zhang, Y.Q.6
Lin, X.J.7
Lau, W.Y.8
-
25
-
-
0029001687
-
Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire
-
PMID: 7708069
-
A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. N Engl J Med 1995; 332: 1256-1261 [PMID: 7708069 DOI: 10.1056/NEJM199505113321903]
-
(1995)
N Engl J Med
, vol.332
, pp. 1256-1261
-
-
-
26
-
-
0037129704
-
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial
-
PMID: 12049862
-
Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Solà R, Rodés J, Bruix J. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359: 1734-1739 [PMID: 12049862 DOI: 10.1016/S0140-6736(02)08649-X]
-
(2002)
Lancet
, vol.359
, pp. 1734-1739
-
-
Llovet, J.M.1
Real, M.I.2
Montaña, X.3
Planas, R.4
Coll, S.5
Aponte, J.6
Ayuso, C.7
Sala, M.8
Muchart, J.9
Solà, R.10
Rodés, J.11
Bruix, J.12
-
27
-
-
0036237822
-
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
-
PMID: 11981766
-
Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST, Wong J. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-1171 [PMID: 11981766 DOI: 10.1053/jhep.2002.33156]
-
(2002)
Hepatology
, vol.35
, pp. 1164-1171
-
-
Lo, C.M.1
Ngan, H.2
Tso, W.K.3
Liu, C.L.4
Lam, C.M.5
Poon, R.T.6
Fan, S.T.7
Wong, J.8
-
28
-
-
2442680770
-
Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: Interim safety and survival data on 65 patients
-
PMID: 14762849
-
Carr BI. Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl 2004; 10: S107-S110 [PMID: 14762849 DOI: 10.1002/lt.20036]
-
(2004)
Liver Transpl
, vol.10
, pp. S107-S110
-
-
Carr, B.I.1
-
29
-
-
79251575901
-
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma
-
PMID: 21044630
-
Salem R, Lewandowski RJ, Kulik L, Wang E, Riaz A, Ryu RK, Sato KT, Gupta R, Nikolaidis P, Miller FH, Yaghmai V, Ibrahim SM, Senthilnathan S, Baker T, Gates VL, Atassi B, Newman S, Memon K, Chen R, Vogelzang RL, Nemcek AA, Resnick SA, Chrisman HB, Carr J, Omary RA, Abecassis M, Benson AB, Mulcahy MF. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 2011; 140: 497-507.e2 [PMID: 21044630 DOI: 10.1053/j.gastro.2010.10.049]
-
(2011)
Gastroenterology
, vol.140
, pp. 497-507e2
-
-
Salem, R.1
Lewandowski, R.J.2
Kulik, L.3
Wang, E.4
Riaz, A.5
Ryu, R.K.6
Sato, K.T.7
Gupta, R.8
Nikolaidis, P.9
Miller, F.H.10
Yaghmai, V.11
Ibrahim, S.M.12
Senthilnathan, S.13
Baker, T.14
Gates, V.L.15
Atassi, B.16
Newman, S.17
Memon, K.18
Chen, R.19
Vogelzang, R.L.20
Nemcek, A.A.21
Resnick, S.A.22
Chrisman, H.B.23
Carr, J.24
Omary, R.A.25
Abecassis, M.26
Benson, A.B.27
Mulcahy, M.F.28
more..
-
30
-
-
47949116252
-
Sorafenib in advanced hepatocellular carcinoma
-
PMID: 18650514
-
Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378-390 [PMID: 18650514 DOI: 10.1056/NEJMoa0708857]
-
(2008)
N Engl J Med
, vol.359
, pp. 378-390
-
-
Llovet, J.M.1
Ricci, S.2
Mazzaferro, V.3
Hilgard, P.4
Gane, E.5
Blanc, J.F.6
De Oliveira, A.C.7
Santoro, A.8
Raoul, J.L.9
Forner, A.10
Schwartz, M.11
Porta, C.12
Zeuzem, S.13
Bolondi, L.14
Greten, T.F.15
Galle, P.R.16
Seitz, J.F.17
Borbath, I.18
Häussinger, D.19
Giannaris, T.20
Shan, M.21
Moscovici, M.22
Voliotis, D.23
Bruix, J.24
more..
-
31
-
-
57749189578
-
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial
-
PMID: 19095497
-
Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, Xu J, Sun Y, Liang H, Liu J, Wang J, Tak WY, Pan H, Burock K, Zou J, Voliotis D, Guan Z. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 2009; 10: 25-34 [PMID: 19095497 DOI: 10.1016/S1470-2045(08)70285-7]
-
(2009)
Lancet Oncol
, vol.10
, pp. 25-34
-
-
Cheng, A.L.1
Kang, Y.K.2
Chen, Z.3
Tsao, C.J.4
Qin, S.5
Kim, J.S.6
Luo, R.7
Feng, J.8
Ye, S.9
Yang, T.S.10
Xu, J.11
Sun, Y.12
Liang, H.13
Liu, J.14
Wang, J.15
Tak, W.Y.16
Pan, H.17
Burock, K.18
Zou, J.19
Voliotis, D.20
Guan, Z.21
more..
-
32
-
-
20344367769
-
Resection and liver transplantation for hepatocellular carcinoma
-
PMID: 15918147
-
Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005; 25: 181-200 [PMID: 15918147 DOI: 10.1055/s-2005-871198]
-
(2005)
Semin Liver Dis
, vol.25
, pp. 181-200
-
-
Llovet, J.M.1
Schwartz, M.2
Mazzaferro, V.3
-
33
-
-
0021337135
-
Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function
-
PMID: 6324403
-
Okamoto E, Kyo A, Yamanaka N, Tanaka N, Kuwata K. Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery 1984; 95: 586-592 [PMID: 6324403]
-
(1984)
Surgery
, vol.95
, pp. 586-592
-
-
Okamoto, E.1
Kyo, A.2
Yamanaka, N.3
Tanaka, N.4
Kuwata, K.5
-
35
-
-
0029842080
-
Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure
-
PMID: 8831597
-
Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, Visa J, Bru C, Rodés J. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996; 111: 1018-1022 [PMID: 8831597]
-
(1996)
Gastroenterology
, vol.111
, pp. 1018-1022
-
-
Bruix, J.1
Castells, A.2
Bosch, J.3
Feu, F.4
Fuster, J.5
Garcia-Pagan, J.C.6
Visa, J.7
Bru, C.8
Rodés, J.9
-
36
-
-
59449108403
-
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population
-
PMID: 19034578
-
Cucchetti A, Piscaglia F, Caturelli E, Benvegnù L, Vivarelli M, Ercolani G, Cescon M, Ravaioli M, Grazi GL, Bolondi L, Pinna AD. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. Ann Surg Oncol 2009; 16: 413-422 [PMID: 19034578 DOI: 10.1245/s10434-008-0232-4]
-
(2009)
Ann Surg Oncol
, vol.16
, pp. 413-422
-
-
Cucchetti, A.1
Piscaglia, F.2
Caturelli, E.3
Benvegnù, L.4
Vivarelli, M.5
Ercolani, G.6
Cescon, M.7
Ravaioli, M.8
Grazi, G.L.9
Bolondi, L.10
Pinna, A.D.11
-
37
-
-
36349022638
-
Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome
-
PMID: 17583900
-
Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 2007; 94: 1386-1394 [PMID: 17583900 DOI: 10.1002/bjs.5836]
-
(2007)
Br J Surg
, vol.94
, pp. 1386-1394
-
-
Ribero, D.1
Abdalla, E.K.2
Madoff, D.C.3
Donadon, M.4
Loyer, E.M.5
Vauthey, J.N.6
-
38
-
-
0037315694
-
Portal vein embolization before right hepatectomy: Prospective clinical trial
-
PMID: 12560779
-
Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V, Denys A, Sauvanet A. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 2003; 237: 208-217 [PMID: 12560779 DOI: 10.1097/01. SLA.0000048447.16651.7B]
-
(2003)
Ann Surg
, vol.237
, pp. 208-217
-
-
Farges, O.1
Belghiti, J.2
Kianmanesh, R.3
Regimbeau, J.M.4
Santoro, R.5
Vilgrain, V.6
Denys, A.7
Sauvanet, A.8
-
39
-
-
77954465970
-
Surgical strategies for hepatocellular carcinoma with special reference to anatomical hepatic resection and intraoperative contrast-enhanced ultrasonography
-
[PMID: 20616594
-
Arii S, Tanaka S, Mitsunori Y, Nakamura N, Kudo A, Noguchi N, Irie T. Surgical strategies for hepatocellular carcinoma with special reference to anatomical hepatic resection and intraoperative contrast-enhanced ultrasonography. Oncology 2010; 78 Suppl 1: 125-130 [PMID: 20616594 DOI: 10.1159/000315240]
-
(2010)
Oncology
, vol.78
, pp. 125-130
-
-
Arii, S.1
Tanaka, S.2
Mitsunori, Y.3
Nakamura, N.4
Kudo, A.5
Noguchi, N.6
Irie, T.7
-
40
-
-
65449170121
-
Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma
-
PMID: 19300227
-
Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, Fong Y, D'Angelica MI, Blumgart LH, Dematteo RP. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 2009; 249: 617-623 [PMID: 19300227 DOI: 10.1097/SLA.0b013e31819ed22f]
-
(2009)
Ann Surg
, vol.249
, pp. 617-623
-
-
Katz, S.C.1
Shia, J.2
Liau, K.H.3
Gonen, M.4
Ruo, L.5
Jarnagin, W.R.6
Fong, Y.7
D'angelica, M.I.8
Blumgart, L.H.9
Dematteo, R.P.10
-
41
-
-
69349099400
-
A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma
-
PMID: 19524573
-
Roayaie S, Blume IN, Thung SN, Guido M, Fiel MI, Hiotis S, Labow DM, Llovet JM, Schwartz ME. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology 2009; 137: 850-855 [PMID: 19524573 DOI: 10.1053/j.gastro.2009.06.003]
-
(2009)
Gastroenterology
, vol.137
, pp. 850-855
-
-
Roayaie, S.1
Blume, I.N.2
Thung, S.N.3
Guido, M.4
Fiel, M.I.5
Hiotis, S.6
Labow, D.M.7
Llovet, J.M.8
Schwartz, M.E.9
-
42
-
-
0037308463
-
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
-
PMID: 12547409
-
Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Takayama T, Kawasaki S, Makuuchi M. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003; 38: 200-207 [PMID: 12547409]
-
(2003)
J Hepatol
, vol.38
, pp. 200-207
-
-
Imamura, H.1
Matsuyama, Y.2
Tanaka, E.3
Ohkubo, T.4
Hasegawa, K.5
Miyagawa, S.6
Sugawara, Y.7
Minagawa, M.8
Takayama, T.9
Kawasaki, S.10
Makuuchi, M.11
-
43
-
-
0033511442
-
Continuous versus intermittent portal triad clamping for liver resection: A controlled study
-
PMID: 10077049
-
Belghiti J, Noun R, Malafosse R, Jagot P, Sauvanet A, Pierangeli F, Marty J, Farges O. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg 1999; 229: 369-375 [PMID: 10077049]
-
(1999)
Ann Surg
, vol.229
, pp. 369-375
-
-
Belghiti, J.1
Noun, R.2
Malafosse, R.3
Jagot, P.4
Sauvanet, A.5
Pierangeli, F.6
Marty, J.7
Farges, O.8
-
44
-
-
15444363832
-
Complete versus selective portal triad clamping for minor liver resections: A prospective randomized trial
-
PMID: 15798459
-
Figueras J, Llado L, Ruiz D, Ramos E, Busquets J, Rafecas A, Torras J, Fabregat J. Complete versus selective portal triad clamping for minor liver resections: a prospective randomized trial. Ann Surg 2005; 241: 582-590 [PMID: 15798459]
-
(2005)
Ann Surg
, vol.241
, pp. 582-590
-
-
Figueras, J.1
Llado, L.2
Ruiz, D.3
Ramos, E.4
Busquets, J.5
Rafecas, A.6
Torras, J.7
Fabregat, J.8
-
45
-
-
44949243078
-
Techniques for liver parenchymal transection in liver resection
-
PMID: 19160307
-
Gurusamy KS, Pamecha V, Sharma D, Davidson BR. Techniques for liver parenchymal transection in liver resection. Cochrane Database Syst Rev 2009; (1): CD006880 [PMID: 19160307 DOI: 10.1002/14651858.CD006880.pub2]
-
(2009)
Cochrane Database Syst Rev
, Issue.1
, pp. CD006880
-
-
Gurusamy, K.S.1
Pamecha, V.2
Sharma, D.3
Davidson, B.R.4
-
46
-
-
0036189906
-
Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: Implications for a strategy of salvage transplantation
-
PMID: 11882759
-
Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002; 235: 373-382 [PMID: 11882759]
-
(2002)
Ann Surg
, vol.235
, pp. 373-382
-
-
Poon, R.T.1
Fan, S.T.2
Lo, C.M.3
Liu, C.L.4
Wong, J.5
-
47
-
-
0036242372
-
Preoperative predictors of survival after resection of small hepatocellular carcinomas
-
discussion 730-1, PMID: 11981219
-
Wayne JD, Lauwers GY, Ikai I, Doherty DA, Belghiti J, Yamaoka Y, Regimbeau JM, Nagorney DM, Do KA, Ellis LM, Curley SA, Pollock RE, Vauthey JN. Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg 2002; 235: 722-30; discussion 730-1 [PMID: 11981219]
-
(2002)
Ann Surg
, vol.235
, pp. 722-730
-
-
Wayne, J.D.1
Lauwers, G.Y.2
Ikai, I.3
Doherty, D.A.4
Belghiti, J.5
Yamaoka, Y.6
Regimbeau, J.M.7
Nagorney, D.M.8
Do, K.A.9
Ellis, L.M.10
Curley, S.A.11
Pollock, R.E.12
Vauthey, J.N.13
-
48
-
-
84861341922
-
Resection of hepatocellular carcinoma without cirrhosis
-
PMID: 22258064
-
Shrager B, Jibara G, Schwartz M, Roayaie S. Resection of hepatocellular carcinoma without cirrhosis. Ann Surg 2012; 255: 1135-1143 [PMID: 22258064 DOI: 10.1097/SLA.0b013e31823e70a3]
-
(2012)
Ann Surg
, vol.255
, pp. 1135-1143
-
-
Shrager, B.1
Jibara, G.2
Schwartz, M.3
Roayaie, S.4
-
49
-
-
84872173374
-
Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: An intentionto-treat analysis
-
PMID: 23036070
-
Sogawa H, Shrager B, Jibara G, Tabrizian P, Roayaie S, Schwartz M. Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intentionto-treat analysis. HPB (Oxford) 2013; 15: 134-141 [PMID: 23036070 DOI: 10.1111/j.1477-2574.2012.00548.x]
-
(2013)
HPB (Oxford)
, vol.15
, pp. 134-141
-
-
Sogawa, H.1
Shrager, B.2
Jibara, G.3
Tabrizian, P.4
Roayaie, S.5
Schwartz, M.6
-
50
-
-
0026047458
-
Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis
-
PMID: 1714267
-
Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991; 214: 114-117 [PMID: 1714267]
-
(1991)
Ann Surg
, vol.214
, pp. 114-117
-
-
Belghiti, J.1
Panis, Y.2
Farges, O.3
Benhamou, J.P.4
Fekete, F.5
-
51
-
-
0037087696
-
Simplified staging for hepatocellular carcinoma
-
PMID: 11896101
-
Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, Curley SA, Ellis LM, Regimbeau JM, Rashid A, Cleary KR, Nagorney DM. Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002; 20: 1527-1536 [PMID: 11896101]
-
(2002)
J Clin Oncol
, vol.20
, pp. 1527-1536
-
-
Vauthey, J.N.1
Lauwers, G.Y.2
Esnaola, N.F.3
Do, K.A.4
Belghiti, J.5
Mirza, N.6
Curley, S.A.7
Ellis, L.M.8
Regimbeau, J.M.9
Rashid, A.10
Cleary, K.R.11
Nagorney, D.M.12
-
52
-
-
0037271963
-
Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients
-
viii, PMID: 12735128
-
Poon RT, Fan ST. Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients. Surg Oncol Clin N Am 2003; 12: 35-50, viii [PMID: 12735128]
-
(2003)
Surg Oncol Clin N Am
, vol.12
, pp. 35-50
-
-
Poon, R.T.1
Fan, S.T.2
-
53
-
-
58149296156
-
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
-
European Association For The Study Of The Liver, PMID: 19054588
-
European Association For The Study Of The Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009; 50: 227-242 [PMID: 19054588 DOI: 10.1016/j.jhep.2008.10.001]
-
(2009)
J Hepatol
, vol.50
, pp. 227-242
-
-
-
54
-
-
33644858331
-
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
-
PMID: 16530509
-
Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006; 130: 678-686 [PMID: 16530509 DOI: 10.1053/j.gastro.2005.11.016]
-
(2006)
Gastroenterology
, vol.130
, pp. 678-686
-
-
Iloeje, U.H.1
Yang, H.I.2
Su, J.3
Jen, C.L.4
You, S.L.5
Chen, C.J.6
-
55
-
-
77950220516
-
Meta-analysis: Interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma
-
PMID: 19732321
-
Miyake Y, Takaki A, Iwasaki Y, Yamamoto K. Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma. J Viral Hepat 2010; 17: 287-292 [PMID: 19732321 DOI: 10.1111/j.1365-2893.2009.01181.x]
-
(2010)
J Viral Hepat
, vol.17
, pp. 287-292
-
-
Miyake, Y.1
Takaki, A.2
Iwasaki, Y.3
Yamamoto, K.4
-
56
-
-
77952422635
-
Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach
-
PMID: 20395009
-
Shen YC, Hsu C, Chen LT, Cheng CC, Hu FC, Cheng AL. Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach. J Hepatol 2010; 52: 889-894 [PMID: 20395009 DOI: 10.1016/j.jhep.2009.12.041]
-
(2010)
J Hepatol
, vol.52
, pp. 889-894
-
-
Shen, Y.C.1
Hsu, C.2
Chen, L.T.3
Cheng, C.C.4
Hu, F.C.5
Cheng, A.L.6
-
57
-
-
84989592159
-
Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma
-
PMID: 8045490
-
Izumi R, Shimizu K, Iyobe T, Ii T, Yagi M, Matsui O, Nonomura A, Miyazaki I. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology 1994; 20: 295-301 [PMID: 8045490]
-
(1994)
Hepatology
, vol.20
, pp. 295-301
-
-
Izumi, R.1
Shimizu, K.2
Iyobe, T.3
Ii, T.4
Yagi, M.5
Matsui, O.6
Nonomura, A.7
Miyazaki, I.8
-
58
-
-
0031914335
-
Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: A randomized controlled trial
-
PMID: 9484732
-
Lai EC, Lo CM, Fan ST, Liu CL, Wong J. Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg 1998; 133: 183-188 [PMID: 9484732]
-
(1998)
Arch Surg
, vol.133
, pp. 183-188
-
-
Lai, E.C.1
Lo, C.M.2
Fan, S.T.3
Liu, C.L.4
Wong, J.5
-
59
-
-
9044254917
-
A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma
-
PMID: 8609071
-
Yamasaki S, Hasegawa H, Kinoshita H, Furukawa M, Imaoka S, Takasaki K, Kakumoto Y, Saitsu H, Yamada R, Oosaki Y, Arii S, Okamoto E, Monden M, Ryu M, Kusano S, Kanematsu T, Ikeda K, Yamamoto M, Saoshiro T, Tsuzuki T. A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res 1996; 87: 206-211 [PMID: 8609071]
-
(1996)
Jpn J Cancer Res
, vol.87
, pp. 206-211
-
-
Yamasaki, S.1
Hasegawa, H.2
Kinoshita, H.3
Furukawa, M.4
Imaoka, S.5
Takasaki, K.6
Kakumoto, Y.7
Saitsu, H.8
Yamada, R.9
Oosaki, Y.10
Arii, S.11
Okamoto, E.12
Monden, M.13
Ryu, M.14
Kusano, S.15
Kanematsu, T.16
Ikeda, K.17
Yamamoto, M.18
Saoshiro, T.19
Tsuzuki, T.20
more..
-
60
-
-
37549046808
-
Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: A prospective randomized trial-update on 5-year and 10-year survival
-
PMID: 18156922
-
Lau WY, Lai EC, Leung TW, Yu SC. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival. Ann Surg 2008; 247: 43-48 [PMID: 18156922 DOI: 10.1097/SLA.0b013e3181571047]
-
(2008)
Ann Surg
, vol.247
, pp. 43-48
-
-
Lau, W.Y.1
Lai, E.C.2
Leung, T.W.3
Yu, S.C.4
-
61
-
-
0030476004
-
Multidisciplinary management of hepatocellular carcinoma
-
PMID: 8975975
-
Lygidakis NJ, Tsiliakos S. Multidisciplinary management of hepatocellular carcinoma. Hepatogastroenterology 1996; 43: 1611-1619 [PMID: 8975975]
-
(1996)
Hepatogastroenterology
, vol.43
, pp. 1611-1619
-
-
Lygidakis, N.J.1
Tsiliakos, S.2
-
62
-
-
0034596475
-
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: A randomised trial
-
PMID: 11022927
-
Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, Shimada K, Sakamoto M, Hirohashi S, Ohashi Y, Kakizoe T. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 2000; 356: 802-807 [PMID: 11022927 DOI: 10.1016/S0140-6736(00)02654-4]
-
(2000)
Lancet
, vol.356
, pp. 802-807
-
-
Takayama, T.1
Sekine, T.2
Makuuchi, M.3
Yamasaki, S.4
Kosuge, T.5
Yamamoto, J.6
Shimada, K.7
Sakamoto, M.8
Hirohashi, S.9
Ohashi, Y.10
Kakizoe, T.11
-
63
-
-
0030012773
-
Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinoma
-
PMID: 8665186
-
Yamamoto M, Arii S, Sugahara K, Tobe T. Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinoma. Br J Surg 1996; 83: 336-340 [PMID: 8665186]
-
(1996)
Br J Surg
, vol.83
, pp. 336-340
-
-
Yamamoto, M.1
Arii, S.2
Sugahara, K.3
Tobe, T.4
-
64
-
-
0035872948
-
Effects of long-term postoperative interferonalpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial
-
PMID: 11352697
-
Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Shuto T, Yamazaki O, Shiomi S, Tamori A, Oka H, Igawa S, Kuroki T, Kinoshita H. Effects of long-term postoperative interferonalpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial. Ann Intern Med 2001; 134: 963-967 [PMID: 11352697]
-
(2001)
Ann Intern Med
, vol.134
, pp. 963-967
-
-
Kubo, S.1
Nishiguchi, S.2
Hirohashi, K.3
Tanaka, H.4
Shuto, T.5
Yamazaki, O.6
Shiomi, S.7
Tamori, A.8
Oka, H.9
Igawa, S.10
Kuroki, T.11
Kinoshita, H.12
-
65
-
-
33845760039
-
Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis
-
PMID: 17133492
-
Mazzaferro V, Romito R, Schiavo M, Mariani L, Camerini T, Bhoori S, Capussotti L, Calise F, Pellicci R, Belli G, Tagger A, Colombo M, Bonino F, Majno P, Llovet JM. Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology 2006; 44: 1543-1554 [PMID: 17133492 DOI: 10.1002/hep.21415]
-
(2006)
Hepatology
, vol.44
, pp. 1543-1554
-
-
Mazzaferro, V.1
Romito, R.2
Schiavo, M.3
Mariani, L.4
Camerini, T.5
Bhoori, S.6
Capussotti, L.7
Calise, F.8
Pellicci, R.9
Belli, G.10
Tagger, A.11
Colombo, M.12
Bonino, F.13
Majno, P.14
Llovet, J.M.15
-
66
-
-
0033528522
-
Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial
-
PMID: 10459961
-
Lau WY, Leung TW, Ho SK, Chan M, Machin D, Lau J, Chan AT, Yeo W, Mok TS, Yu SC, Leung NW, Johnson PJ. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet 1999; 353: 797-801 [PMID: 10459961]
-
(1999)
Lancet
, vol.353
, pp. 797-801
-
-
Lau, W.Y.1
Leung, T.W.2
Ho, S.K.3
Chan, M.4
Machin, D.5
Lau, J.6
Chan, A.T.7
Yeo, W.8
Mok, T.S.9
Yu, S.C.10
Leung, N.W.11
Johnson, P.J.12
-
67
-
-
0142182774
-
Adjuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma
-
PMID: 14578862
-
Boucher E, Corbinais S, Rolland Y, Bourguet P, Guyader D, Boudjema K, Meunier B, Raoul JL. Adjuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma. Hepatology 2003; 38: 1237-1241 [PMID: 14578862 DOI: 10.1053/jhep.2003.50473]
-
(2003)
Hepatology
, vol.38
, pp. 1237-1241
-
-
Boucher, E.1
Corbinais, S.2
Rolland, Y.3
Bourguet, P.4
Guyader, D.5
Boudjema, K.6
Meunier, B.7
Raoul, J.L.8
-
68
-
-
5844370499
-
Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma
-
Hepatoma Prevention Study Group, PMID: 8628336
-
Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, Tsurumi K, Okuno M, Tomita E, Nakamura T, Kojima T. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med 1996; 334: 1561-1567 [PMID: 8628336 DOI: 10.1056/NEJM199606133342402]
-
(1996)
N Engl J Med
, vol.334
, pp. 1561-1567
-
-
Muto, Y.1
Moriwaki, H.2
Ninomiya, M.3
Adachi, S.4
Saito, A.5
Takasaki, K.T.6
Tanaka, T.7
Tsurumi, K.8
Okuno, M.9
Tomita, E.10
Nakamura, T.11
Kojima, T.12
-
69
-
-
67649237427
-
Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma
-
PMID: 19160192
-
Samuel M, Chow PK, Chan Shih-Yen E, Machin D, Soo KC. Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Cochrane Database Syst Rev 2009; (1): CD001199 [PMID: 19160192 DOI: 10.1002/14651858. CD001199.pub2]
-
(2009)
Cochrane Database Syst Rev
, Issue.1
, pp. CD001199
-
-
Samuel, M.1
Chow, P.K.2
Chan Shih-Yen, E.3
Machin, D.4
Soo, K.C.5
-
70
-
-
77951296192
-
Clinical trials of note. Sorafenib as adjuvant treatment in the prevention of disease recurrence in patients with hepatocellular carcinoma (HCC) (STORM)
-
PMID: 19806596
-
Printz C. Clinical trials of note. Sorafenib as adjuvant treatment in the prevention of disease recurrence in patients with hepatocellular carcinoma (HCC) (STORM). Cancer 2009; 115: 4646 [PMID: 19806596 DOI: 10.1002/cncr.24673]
-
(2009)
Cancer
, vol.115
, pp. 4646
-
-
Printz, C.1
-
71
-
-
79960449876
-
Second hepatic resection for recurrent hepatocellular cancer: A Western experience
-
PMID: 21147184
-
Roayaie S, Bassi D, Tarchi P, Labow D, Schwartz M. Second hepatic resection for recurrent hepatocellular cancer: a Western experience. J Hepatol 2011; 55: 346-350 [PMID: 21147184 DOI: 10.1016/j.jhep.2010.11.026]
-
(2011)
J Hepatol
, vol.55
, pp. 346-350
-
-
Roayaie, S.1
Bassi, D.2
Tarchi, P.3
Labow, D.4
Schwartz, M.5
-
72
-
-
17144438939
-
Hepatocellular carcinoma: Surgical indications and results
-
PMID: 12853096
-
Marín-Hargreaves G, Azoulay D, Bismuth H. Hepatocellular carcinoma: surgical indications and results. Crit Rev Oncol Hematol 2003; 47: 13-27 [PMID: 12853096]
-
(2003)
Crit Rev Oncol Hematol
, vol.47
, pp. 13-27
-
-
Marín-Hargreaves, G.1
Azoulay, D.2
Bismuth, H.3
-
73
-
-
0034077090
-
Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: An outcome-oriented decision analysis
-
PMID: 10733546
-
Majno PE, Sarasin FP, Mentha G, Hadengue A. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology 2000; 31: 899-906 [PMID: 10733546 DOI: 10.1053/he.2000.5763]
-
(2000)
Hepatology
, vol.31
, pp. 899-906
-
-
Majno, P.E.1
Sarasin, F.P.2
Mentha, G.3
Hadengue, A.4
-
74
-
-
0842289167
-
Resection prior to liver transplantation for hepatocellular carcinoma
-
discussion 892-3, PMID: 14631225
-
Belghiti J, Cortes A, Abdalla EK, Régimbeau JM, Prakash K, Durand F, Sommacale D, Dondero F, Lesurtel M, Sauvanet A, Farges O, Kianmanesh R. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 2003; 238: 885-92; discussion 892-3 [PMID: 14631225 DOI: 10.1097/01. sla.0000098621.74851.65]
-
(2003)
Ann Surg
, vol.238
, pp. 885-892
-
-
Belghiti, J.1
Cortes, A.2
Abdalla, E.K.3
Régimbeau, J.M.4
Prakash, K.5
Durand, F.6
Sommacale, D.7
Dondero, F.8
Lesurtel, M.9
Sauvanet, A.10
Farges, O.11
Kianmanesh, R.12
-
75
-
-
10744220026
-
Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: A reasonable strategy?
-
discussion 518-9, PMID: 14530722
-
Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, Samuel D, Bismuth H. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg 2003; 238: 508-18; discussion 518-9 [PMID: 14530722 DOI: 10.1097/01. sla.0000090449.87109.44]
-
(2003)
Ann Surg
, vol.238
, pp. 508-518
-
-
Adam, R.1
Azoulay, D.2
Castaing, D.3
Eshkenazy, R.4
Pascal, G.5
Hashizume, K.6
Samuel, D.7
Bismuth, H.8
-
76
-
-
70449382145
-
Liver resection for transplantable hepatocellular carcinoma: Long-term survival and role of secondary liver transplantation
-
PMID: 19801927
-
Cherqui D, Laurent A, Mocellin N, Tayar C, Luciani A, Van Nhieu JT, Decaens T, Hurtova M, Memeo R, Mallat A, Duvoux C. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg 2009; 250: 738-746 [PMID: 19801927 DOI: 10.1097/SLA.0b013e3181bd582b]
-
(2009)
Ann Surg
, vol.250
, pp. 738-746
-
-
Cherqui, D.1
Laurent, A.2
Mocellin, N.3
Tayar, C.4
Luciani, A.5
Van Nhieu, J.T.6
Decaens, T.7
Hurtova, M.8
Memeo, R.9
Mallat, A.10
Duvoux, C.11
-
77
-
-
0033503797
-
Intrahepatic recurrence after curative resection of hepatocellular carcinoma: Long-term results of treatment and prognostic factors
-
PMID: 10024103
-
Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999; 229: 216-222 [PMID: 10024103]
-
(1999)
Ann Surg
, vol.229
, pp. 216-222
-
-
Poon, R.T.1
Fan, S.T.2
Lo, C.M.3
Liu, C.L.4
Wong, J.5
-
78
-
-
84862802146
-
Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: Comparative effectiveness of treatment modalities
-
PMID: 22284764
-
Ho CM, Lee PH, Shau WY, Ho MC, Wu YM, Hu RH. Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities. Surgery 2012; 151: 700-709 [PMID: 22284764 DOI: 10.1016/j.surg.2011.12.015]
-
(2012)
Surgery
, vol.151
, pp. 700-709
-
-
Ho, C.M.1
Lee, P.H.2
Shau, W.Y.3
Ho, M.C.4
Wu, Y.M.5
Hu, R.H.6
-
79
-
-
1942500153
-
Recurrent hepatocellular carcinoma after hepatic resection: Prognostic factors and long-term outcome
-
PMID: 15063895
-
Chen WT, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Wu CW. Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome. Eur J Surg Oncol 2004; 30: 414-420 [PMID: 15063895 DOI: 10.1016/j.ejso.2004.01.013]
-
(2004)
Eur J Surg Oncol
, vol.30
, pp. 414-420
-
-
Chen, W.T.1
Chau, G.Y.2
Lui, W.Y.3
Tsay, S.H.4
King, K.L.5
Loong, C.C.6
Wu, C.W.7
-
80
-
-
80052835583
-
Repeat treatment for recurrent hepatocellular carcinoma: Is it validated?
-
PMID: 21847622
-
Kishi Y, Saiura A, Yamamoto J, Koga R, Seki M, Morimura R, Yoshioka R, Kokudo N, Yamaguchi T. Repeat treatment for recurrent hepatocellular carcinoma: is it validated? Langenbecks Arch Surg 2011; 396: 1093-1100 [PMID: 21847622 DOI: 10.1007/s00423-011-0837-0]
-
(2011)
Langenbecks Arch Surg
, vol.396
, pp. 1093-1100
-
-
Kishi, Y.1
Saiura, A.2
Yamamoto, J.3
Koga, R.4
Seki, M.5
Morimura, R.6
Yoshioka, R.7
Kokudo, N.8
Yamaguchi, T.9
-
81
-
-
0031691340
-
Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma
-
PMID: 9752858
-
Lam CM, Lo CM, Yuen WK, Liu CL, Fan ST. Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg 1998; 85: 1198-1200 [PMID: 9752858 DOI: 10.1046/j.1365-2168.1998.00846.x]
-
(1998)
Br J Surg
, vol.85
, pp. 1198-1200
-
-
Lam, C.M.1
Lo, C.M.2
Yuen, W.K.3
Liu, C.L.4
Fan, S.T.5
-
82
-
-
0032877161
-
Liver transplantation for hepatocellular carcinoma
-
PMID: 10518310
-
Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 1999; 19: 311-322 [PMID: 10518310 DOI: 10.1055/s-2007-1007120]
-
(1999)
Semin Liver Dis
, vol.19
, pp. 311-322
-
-
Bismuth, H.1
Majno, P.E.2
Adam, R.3
-
83
-
-
0035028451
-
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis
-
PMID: 11343235
-
Jonas S, Bechstein WO, Steinmüller T, Herrmann M, Radke C, Berg T, Settmacher U, Neuhaus P. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080-1086 [PMID: 11343235 DOI: 10.1053/jhep.2001.23561]
-
(2001)
Hepatology
, vol.33
, pp. 1080-1086
-
-
Jonas, S.1
Bechstein, W.O.2
Steinmüller, T.3
Herrmann, M.4
Radke, C.5
Berg, T.6
Settmacher, U.7
Neuhaus, P.8
-
84
-
-
0842305761
-
Adult living donor liver transplantation for patients with hepatocellular carcinoma: Extending UNOS priority criteria
-
PMID: 14745320
-
Gondolesi GE, Roayaie S, Muñoz L, Kim-Schluger L, Schiano T, Fishbein TM, Emre S, Miller CM, Schwartz ME. Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg 2004; 239: 142-149 [PMID: 14745320 DOI: 10.1097/01. sla.0000109022.32391.eb]
-
(2004)
Ann Surg
, vol.239
, pp. 142-149
-
-
Gondolesi, G.E.1
Roayaie, S.2
Muñoz, L.3
Kim-Schluger, L.4
Schiano, T.5
Fishbein, T.M.6
Emre, S.7
Miller, C.M.8
Schwartz, M.E.9
-
85
-
-
4344652107
-
Japanese Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma: Experience in Japan
-
discussion 459-61, PMID: 15319716
-
Todo S, Furukawa H; Japanese Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 2004; 240: 451-49; discussion 459-61 [PMID: 15319716]
-
(2004)
Ann Surg
, vol.240
, pp. 451-549
-
-
Todo, S.1
Furukawa, H.2
-
86
-
-
35548932526
-
HCC in living donor liver transplantation: Can we expand the Milan criteria?
-
PMID: 17960066
-
Kwon CH, Kim DJ, Han YS, Park JB, Choi GS, Kim SJ, Joh JW, Lee SK. HCC in living donor liver transplantation: can we expand the Milan criteria? Dig Dis 2007; 25: 313-319 [PMID: 17960066 DOI: 10.1159/000106911]
-
(2007)
Dig Dis
, vol.25
, pp. 313-319
-
-
Kwon, C.H.1
Kim, D.J.2
Han, Y.S.3
Park, J.B.4
Choi, G.S.5
Kim, S.J.6
Joh, J.W.7
Lee, S.K.8
-
87
-
-
48949120266
-
Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center
-
PMID: 18581465
-
Lee SG, Hwang S, Moon DB, Ahn CS, Kim KH, Sung KB, Ko GY, Park KM, Ha TY, Song GW. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. Liver Transpl 2008; 14: 935-945 [PMID: 18581465 DOI: 10.1002/lt.21445]
-
(2008)
Liver Transpl
, vol.14
, pp. 935-945
-
-
Lee, S.G.1
Hwang, S.2
Moon, D.B.3
Ahn, C.S.4
Kim, K.H.5
Sung, K.B.6
Ko, G.Y.7
Park, K.M.8
Ha, T.Y.9
Song, G.W.10
-
88
-
-
0034913550
-
Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma
-
PMID: 11460231
-
Herrero JI, Sangro B, Quiroga J, Pardo F, Herraiz M, Cienfuegos JA, Prieto J. Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl 2001; 7: 631-636 [PMID: 11460231 DOI: 10.1053/jlts.2001.25458]
-
(2001)
Liver Transpl
, vol.7
, pp. 631-636
-
-
Herrero, J.I.1
Sangro, B.2
Quiroga, J.3
Pardo, F.4
Herraiz, M.5
Cienfuegos, J.A.6
Prieto, J.7
-
89
-
-
34250618333
-
Living donor liver transplantation of the right lobe for hepatocellular carcinoma in cirrhosis in a European center
-
PMID: 17538994
-
Jonas S, Mittler J, Pascher A, Schumacher G, Theruvath T, Benckert C, Rudolph B, Neuhaus P. Living donor liver transplantation of the right lobe for hepatocellular carcinoma in cirrhosis in a European center. Liver Transpl 2007; 13: 896-903 [PMID: 17538994 DOI: 10.1002/lt.21189]
-
(2007)
Liver Transpl
, vol.13
, pp. 896-903
-
-
Jonas, S.1
Mittler, J.2
Pascher, A.3
Schumacher, G.4
Theruvath, T.5
Benckert, C.6
Rudolph, B.7
Neuhaus, P.8
-
90
-
-
49649104491
-
Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma
-
PMID: 18668667
-
Toso C, Trotter J, Wei A, Bigam DL, Shah S, Lancaster J, Grant DR, Greig PD, Shapiro AM, Kneteman NM. Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 2008; 14: 1107-1115 [PMID: 18668667 DOI: 10.1002/lt.21484]
-
(2008)
Liver Transpl
, vol.14
, pp. 1107-1115
-
-
Toso, C.1
Trotter, J.2
Wei, A.3
Bigam, D.L.4
Shah, S.5
Lancaster, J.6
Grant, D.R.7
Greig, P.D.8
Shapiro, A.M.9
Kneteman, N.M.10
-
91
-
-
35548934671
-
Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series
-
PMID: 17960065
-
Sugawara Y, Tamura S, Makuuchi M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis 2007; 25: 310-312 [PMID: 17960065 DOI: 10.1159/000106910]
-
(2007)
Dig Dis
, vol.25
, pp. 310-312
-
-
Sugawara, Y.1
Tamura, S.2
Makuuchi, M.3
-
92
-
-
40449097658
-
A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria
-
PMID: 18318783
-
Volk ML, Vijan S, Marrero JA. A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria. Am J Transplant 2008; 8: 839-846 [PMID: 18318783 DOI: 10.1111/j.1600-6143.2007.02138.x]
-
(2008)
Am J Transplant
, vol.8
, pp. 839-846
-
-
Volk, M.L.1
Vijan, S.2
Marrero, J.A.3
-
93
-
-
34548174494
-
Liver transplantation criteria for hepatocellular carcinoma should be expanded: A 22-year experience with 467 patients at UCLA
-
discussion 502-59; PMID: 17717454
-
Duffy JP, Vardanian A, Benjamin E, Watson M, Farmer DG, Ghobrial RM, Lipshutz G, Yersiz H, Lu DS, Lassman C, Tong MJ, Hiatt JR, Busuttil RW. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg 2007; 246: 502-59; discussion 502-59; [PMID: 17717454 DOI: 10.1097/SLA.0b013e318148c704]
-
(2007)
Ann Surg
, vol.246
, pp. 502-559
-
-
Duffy, J.P.1
Vardanian, A.2
Benjamin, E.3
Watson, M.4
Farmer, D.G.5
Ghobrial, R.M.6
Lipshutz, G.7
Yersiz, H.8
Lu, D.S.9
Lassman, C.10
Tong, M.J.11
Hiatt, J.R.12
Busuttil, R.W.13
-
94
-
-
7044234929
-
Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy
-
PMID: 15508092
-
Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 2004; 127: S261-S267 [PMID: 15508092]
-
(2004)
Gastroenterology
, vol.127
, pp. S261-S267
-
-
Wiesner, R.H.1
Freeman, R.B.2
Mulligan, D.C.3
-
95
-
-
37149051811
-
Overview of the MELD score and the UNOS adult liver allocation system
-
PMID: 18089345
-
Martin AP, Bartels M, Hauss J, Fangmann J. Overview of the MELD score and the UNOS adult liver allocation system. Transplant Proc 2007; 39: 3169-3174 [PMID: 18089345 DOI: 10.1016/j.transproceed.2007.04.025]
-
(2007)
Transplant Proc
, vol.39
, pp. 3169-3174
-
-
Martin, A.P.1
Bartels, M.2
Hauss, J.3
Fangmann, J.4
-
96
-
-
72549115627
-
Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: A critical factor
-
PMID: 20070666
-
Vibert E, Azoulay D, Hoti E, Iacopinelli S, Samuel D, Salloum C, Lemoine A, Bismuth H, Castaing D, Adam R. Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transplant 2010; 10: 129-137 [PMID: 20070666 DOI: 10.1111/j.1600-6143.2009.02750.x]
-
(2010)
Am J Transplant
, vol.10
, pp. 129-137
-
-
Vibert, E.1
Azoulay, D.2
Hoti, E.3
Iacopinelli, S.4
Samuel, D.5
Salloum, C.6
Lemoine, A.7
Bismuth, H.8
Castaing, D.9
Adam, R.10
-
97
-
-
36448934513
-
Management of hepatocellular carcinoma on the waiting list before liver transplantation: Time for controlled trials?
-
PMID: 17969086
-
Majno P, Giostra E, Mentha G. Management of hepatocellular carcinoma on the waiting list before liver transplantation: time for controlled trials? Liver Transpl 2007; 13: S27-S35 [PMID: 17969086 DOI: 10.1002/lt.21328]
-
(2007)
Liver Transpl
, vol.13
, pp. S27-S35
-
-
Majno, P.1
Giostra, E.2
Mentha, G.3
-
98
-
-
7044239577
-
Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: A prospective study
-
PMID: 15492574
-
Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, Sarli D, Schiavo M, Garbagnati F, Marchianò A, Spreafico C, Camerini T, Mariani L, Miceli R, Andreola S. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004; 240: 900-909 [PMID: 15492574]
-
(2004)
Ann Surg
, vol.240
, pp. 900-909
-
-
Mazzaferro, V.1
Battiston, C.2
Perrone, S.3
Pulvirenti, A.4
Regalia, E.5
Romito, R.6
Sarli, D.7
Schiavo, M.8
Garbagnati, F.9
Marchianò, A.10
Spreafico, C.11
Camerini, T.12
Mariani, L.13
Miceli, R.14
Andreola, S.15
-
99
-
-
0038173318
-
Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome
-
PMID: 12783395
-
Graziadei IW, Sandmueller H, Waldenberger P, Koenigsrainer A, Nachbaur K, Jaschke W, Margreiter R, Vogel W. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003; 9: 557-563 [PMID: 12783395 DOI: 10.1053/jlts.2003.50106]
-
(2003)
Liver Transpl
, vol.9
, pp. 557-563
-
-
Graziadei, I.W.1
Sandmueller, H.2
Waldenberger, P.3
Koenigsrainer, A.4
Nachbaur, K.5
Jaschke, W.6
Margreiter, R.7
Vogel, W.8
-
100
-
-
51349117878
-
Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: An intention-to-treat analysis
-
PMID: 18688876
-
Yao FY, Kerlan RK, Hirose R, Davern TJ, Bass NM, Feng S, Peters M, Terrault N, Freise CE, Ascher NL, Roberts JP. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 2008; 48: 819-827 [PMID: 18688876 DOI: 10.1002/hep.22412]
-
(2008)
Hepatology
, vol.48
, pp. 819-827
-
-
Yao, F.Y.1
Kerlan, R.K.2
Hirose, R.3
Davern, T.J.4
Bass, N.M.5
Feng, S.6
Peters, M.7
Terrault, N.8
Freise, C.E.9
Ascher, N.L.10
Roberts, J.P.11
-
101
-
-
55949123393
-
Liver transplantation for hepatocellular carcinoma: Results of down-staging in patients initially outside the Milan selection criteria
-
PMID: 19032223
-
Ravaioli M, Grazi GL, Piscaglia F, Trevisani F, Cescon M, Ercolani G, Vivarelli M, Golfieri R, D'Errico Grigioni A, Panzini I, Morelli C, Bernardi M, Bolondi L, Pinna AD. Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transplant 2008; 8: 2547-2557 [PMID: 19032223 DOI: 10.1111/j.1600-6143.2008.02409.x]
-
(2008)
Am J Transplant
, vol.8
, pp. 2547-2557
-
-
Ravaioli, M.1
Grazi, G.L.2
Piscaglia, F.3
Trevisani, F.4
Cescon, M.5
Ercolani, G.6
Vivarelli, M.7
Golfieri, R.8
D'errico Grigioni, A.9
Panzini, I.10
Morelli, C.11
Bernardi, M.12
Bolondi, L.13
Pinna, A.D.14
-
102
-
-
77953181531
-
The challenges of liver transplantation for hepatocellular carcinoma on cirrhosis
-
PMID: 20492616
-
Bhoori S, Sposito C, Germini A, Coppa J, Mazzaferro V. The challenges of liver transplantation for hepatocellular carcinoma on cirrhosis. Transpl Int 2010; 23: 712-722 [PMID: 20492616 DOI: 10.1111/j.1432-2277.2010.01111.x]
-
(2010)
Transpl Int
, vol.23
, pp. 712-722
-
-
Bhoori, S.1
Sposito, C.2
Germini, A.3
Coppa, J.4
Mazzaferro, V.5
-
103
-
-
84855314307
-
Recommendations for liver transplantation for hepatocellular carcinoma: An international consensus conference report
-
PMID: 22047762
-
Clavien PA, Lesurtel M, Bossuyt PM, Gores GJ, Langer B, Perrier A. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol 2012; 13: e11-e22 [PMID: 22047762 DOI: 10.1016/S1470-2045(11)70175-9]
-
(2012)
Lancet Oncol
, vol.13
, pp. e11-e22
-
-
Clavien, P.A.1
Lesurtel, M.2
Bossuyt, P.M.3
Gores, G.J.4
Langer, B.5
Perrier, A.6
-
104
-
-
33846455773
-
Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma
-
PMID: 17016793
-
Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 2007; 94: 78-86 [PMID: 17016793 DOI: 10.1002/bjs.5528]
-
(2007)
Br J Surg
, vol.94
, pp. 78-86
-
-
Lo, C.M.1
Fan, S.T.2
Liu, C.L.3
Chan, S.C.4
Ng, I.O.5
Wong, J.6
-
105
-
-
34248634598
-
Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation
-
PMID: 17511683
-
Fisher RA, Kulik LM, Freise CE, Lok AS, Shearon TH, Brown RS, Ghobrial RM, Fair JH, Olthoff KM, Kam I, Berg CL. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 2007; 7: 1601-1608 [PMID: 17511683 DOI: 10.1111/j.1600-6143.2007.01802.x]
-
(2007)
Am J Transplant
, vol.7
, pp. 1601-1608
-
-
Fisher, R.A.1
Kulik, L.M.2
Freise, C.E.3
Lok, A.S.4
Shearon, T.H.5
Brown, R.S.6
Ghobrial, R.M.7
Fair, J.H.8
Olthoff, K.M.9
Kam, I.10
Berg, C.L.11
-
106
-
-
80053267175
-
Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: A review and consensus statement
-
PMID: 21748847
-
Prasad KR, Young RS, Burra P, Zheng SS, Mazzaferro V, Moon DB, Freeman RB. Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement. Liver Transpl 2011; 17 Suppl 2: S81-S89 [PMID: 21748847 DOI: 10.1002/lt.22380]
-
(2011)
Liver Transpl
, vol.17
, pp. S81-S89
-
-
Prasad, K.R.1
Young, R.S.2
Burra, P.3
Zheng, S.S.4
Mazzaferro, V.5
Moon, D.B.6
Freeman, R.B.7
-
107
-
-
33745498592
-
Living donor liver transplantation for hepatocellular carcinoma exceeding conventional criteria: Questions, answers and demands for a common language
-
PMID: 16721768
-
Majno P, Mazzaferro V. Living donor liver transplantation for hepatocellular carcinoma exceeding conventional criteria: questions, answers and demands for a common language. Liver Transpl 2006; 12: 896-898 [PMID: 16721768 DOI: 10.1002/lt.20808]
-
(2006)
Liver Transpl
, vol.12
, pp. 896-898
-
-
Majno, P.1
Mazzaferro, V.2
-
108
-
-
0026378112
-
Hepatic resection versus transplantation for hepatocellular carcinoma
-
discussion 228-9. PMID: 1656903
-
Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, Todo S, Tzakis AG, Van Thiel DH, Carr B, Selby R. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991; 214: 221-28; discussion 228-9 [PMID: 1656903]
-
(1991)
Ann Surg
, vol.214
, pp. 221-228
-
-
Iwatsuki, S.1
Starzl, T.E.2
Sheahan, D.G.3
Yokoyama, I.4
Demetris, A.J.5
Todo, S.6
Tzakis, A.G.7
Van Thiel, D.H.8
Carr, B.9
Selby, R.10
-
109
-
-
0027170844
-
Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients
-
PMID: 8393649
-
Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993; 218: 145-151 [PMID: 8393649]
-
(1993)
Ann Surg
, vol.218
, pp. 145-151
-
-
Bismuth, H.1
Chiche, L.2
Adam, R.3
Castaing, D.4
Diamond, T.5
Dennison, A.6
-
110
-
-
0033636481
-
Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: A western experience
-
PMID: 11129425
-
Roayaie S, Haim MB, Emre S, Fishbein TM, Sheiner PA, Miller CM, Schwartz ME. Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience. Ann Surg Oncol 2000; 7: 764-770 [PMID: 11129425]
-
(2000)
Ann Surg Oncol
, vol.7
, pp. 764-770
-
-
Roayaie, S.1
Haim, M.B.2
Emre, S.3
Fishbein, T.M.4
Sheiner, P.A.5
Miller, C.M.6
Schwartz, M.E.7
-
111
-
-
0036399763
-
Liver transplantation for hepatocellular carcinoma
-
PMID: 12370659
-
Hemming AW, Nelson DR, Reed AI. Liver transplantation for hepatocellular carcinoma. Minerva Chir 2002; 57: 575-585 [PMID: 12370659]
-
(2002)
Minerva Chir
, vol.57
, pp. 575-585
-
-
Hemming, A.W.1
Nelson, D.R.2
Reed, A.I.3
-
112
-
-
70350524739
-
Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria
-
PMID: 19790142
-
D'Amico F, Schwartz M, Vitale A, Tabrizian P, Roayaie S, Thung S, Guido M, del Rio Martin J, Schiano T, Cillo U. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transpl 2009; 15: 1278-1287 [PMID: 19790142 DOI: 10.1002/lt.21842]
-
(2009)
Liver Transpl
, vol.15
, pp. 1278-1287
-
-
D'amico, F.1
Schwartz, M.2
Vitale, A.3
Tabrizian, P.4
Roayaie, S.5
Thung, S.6
Guido, M.7
Del Rio Martin, J.8
Schiano, T.9
Cillo, U.10
-
113
-
-
34250772448
-
Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis
-
PMID: 17539001
-
Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis. Liver Transpl 2007; 13: 807-813 [PMID: 17539001 DOI: 10.1002/lt.21054]
-
(2007)
Liver Transpl
, vol.13
, pp. 807-813
-
-
Bozorgzadeh, A.1
Orloff, M.2
Abt, P.3
Tsoulfas, G.4
Younan, D.5
Kashyap, R.6
Jain, A.7
Mantry, P.8
Maliakkal, B.9
Khorana, A.10
Schwartz, S.11
-
114
-
-
28844480321
-
Management of hepatocellular carcinoma
-
PMID: 16250051
-
Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236 [PMID: 16250051 DOI: 10.1002/hep.20933]
-
(2005)
Hepatology
, vol.42
, pp. 1208-1236
-
-
Bruix, J.1
Sherman, M.2
-
115
-
-
1842424643
-
Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis
-
PMID: 15048797
-
Roayaie S, Schwartz JD, Sung MW, Emre SH, Miller CM, Gondolesi GE, Krieger NR, Schwartz ME. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 2004; 10: 534-540 [PMID: 15048797 DOI: 10.1002/lt.20128]
-
(2004)
Liver Transpl
, vol.10
, pp. 534-540
-
-
Roayaie, S.1
Schwartz, J.D.2
Sung, M.W.3
Emre, S.H.4
Miller, C.M.5
Gondolesi, G.E.6
Krieger, N.R.7
Schwartz, M.E.8
-
116
-
-
24344486114
-
How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?
-
PMID: 16120468
-
Schwartz M, Roayaie S, Llovet J. How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated? J Hepatol 2005; 43: 584-589 [PMID: 16120468 DOI: 10.1016/j.jhep.2005.07.019]
-
(2005)
J Hepatol
, vol.43
, pp. 584-589
-
-
Schwartz, M.1
Roayaie, S.2
Llovet, J.3
-
117
-
-
77956339306
-
Improved results of a surgical resection for the recurrence of hepatocellular carcinoma after living donor liver transplantation
-
PMID: 20204531
-
Taketomi A, Fukuhara T, Morita K, Kayashima H, Ninomiya M, Yamashita Y, Ikegami T, Uchiyama H, Yoshizumi T, Soejima Y, Shirabe K, Maehara Y. Improved results of a surgical resection for the recurrence of hepatocellular carcinoma after living donor liver transplantation. Ann Surg Oncol 2010; 17: 2283-2289 [PMID: 20204531 DOI: 10.1245/s10434-010-0999-y]
-
(2010)
Ann Surg Oncol
, vol.17
, pp. 2283-2289
-
-
Taketomi, A.1
Fukuhara, T.2
Morita, K.3
Kayashima, H.4
Ninomiya, M.5
Yamashita, Y.6
Ikegami, T.7
Uchiyama, H.8
Yoshizumi, T.9
Soejima, Y.10
Shirabe, K.11
Maehara, Y.12
-
118
-
-
76449093046
-
Chemoembolization with lobaplatin mixed with iodized oil for unresectable recurrent hepatocellular carcinoma after orthotopic liver transplantation
-
PMID: 20116286
-
Zhou B, Shan H, Zhu KS, Jiang ZB, Guan SH, Meng XC, Zeng XC. Chemoembolization with lobaplatin mixed with iodized oil for unresectable recurrent hepatocellular carcinoma after orthotopic liver transplantation. J Vasc Interv Radiol 2010; 21: 333-338 [PMID: 20116286 DOI: 10.1016/j.jvir.2009.11.006]
-
(2010)
J Vasc Interv Radiol
, vol.21
, pp. 333-338
-
-
Zhou, B.1
Shan, H.2
Zhu, K.S.3
Jiang, Z.B.4
Guan, S.H.5
Meng, X.C.6
Zeng, X.C.7
-
119
-
-
35948996946
-
Retransplantation for de novo hepatocellular carcinoma in a liver allograft with recurrent hepatitis B cirrhosis 14 years after primary liver transplantation
-
PMID: 17404871
-
Kita Y, Klintmalm G, Kobayashi S, Yanaga K. Retransplantation for de novo hepatocellular carcinoma in a liver allograft with recurrent hepatitis B cirrhosis 14 years after primary liver transplantation. Dig Dis Sci 2007; 52: 3392-3393 [PMID: 17404871 DOI: 10.1007/s10620-006-9574-6]
-
(2007)
Dig Dis Sci
, vol.52
, pp. 3392-3393
-
-
Kita, Y.1
Klintmalm, G.2
Kobayashi, S.3
Yanaga, K.4
-
120
-
-
58749085407
-
Early liver retransplantation versus late liver retransplantation: Analysis of a single-center experience
-
PMID: 19080262
-
Chen GH, Fu BS, Yang Y, Cai CJ, Lu MQ, Li H, Wang GS, Yi SH, Xu C, Zhang JF, Zhang T, Wang GY. Early liver retransplantation versus late liver retransplantation: analysis of a single-center experience. Chin Med J (Engl) 2008; 121: 1992-1996 [PMID: 19080262]
-
(2008)
Chin Med J (Engl)
, vol.121
, pp. 1992-1996
-
-
Chen, G.H.1
Fu, B.S.2
Yang, Y.3
Cai, C.J.4
Lu, M.Q.5
Li, H.6
Wang, G.S.7
Yi, S.H.8
Xu, C.9
Zhang, J.F.10
Zhang, T.11
Wang, G.Y.12
-
121
-
-
77955699976
-
Loco-regional treatment of hepatocellular carcinoma
-
PMID: 20564355
-
Lencioni R. Loco-regional treatment of hepatocellular carcinoma. Hepatology 2010; 52: 762-773 [PMID: 20564355 DOI: 10.1002/hep.23725]
-
(2010)
Hepatology
, vol.52
, pp. 762-773
-
-
Lencioni, R.1
-
122
-
-
22344454922
-
A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma
-
PMID: 16012942
-
Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, Ishikawa T, Koike Y, Yoshida H, Kawabe T, Omata M. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastro-enterology 2005; 129: 122-130 [PMID: 16012942]
-
(2005)
Gastro-enterology
, vol.129
, pp. 122-130
-
-
Shiina, S.1
Teratani, T.2
Obi, S.3
Sato, S.4
Tateishi, R.5
Fujishima, T.6
Ishikawa, T.7
Koike, Y.8
Yoshida, H.9
Kawabe, T.10
Omata, M.11
-
123
-
-
17044368307
-
A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma
-
viii [PMID: 15831275
-
Lencioni R, Crocetti L. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma. Clin Liver Dis 2005; 9: 301-14, viii [PMID: 15831275 DOI: 10.1016/j.cld.2004.12.002]
-
(2005)
Clin Liver Dis
, vol.9
, pp. 301-314
-
-
Lencioni, R.1
Crocetti, L.2
-
124
-
-
23844541763
-
Complications of radiofrequency ablation in hepatocellular carcinoma
-
PMID: 15688113
-
Rhim H. Complications of radiofrequency ablation in hepatocellular carcinoma. Abdom Imaging 2005; 30: 409-418 [PMID: 15688113 DOI: 10.1007/s00261-004-0255-7]
-
(2005)
Abdom Imaging
, vol.30
, pp. 409-418
-
-
Rhim, H.1
-
125
-
-
42749093603
-
Image-guided thermal ablation of hepatocellular carcinoma
-
PMID: 18304832
-
Lencioni R, Crocetti L. Image-guided thermal ablation of hepatocellular carcinoma. Crit Rev Oncol Hematol 2008; 66: 200-207 [PMID: 18304832 DOI: 10.1016/j.critrevonc.2008.01.0 03]
-
(2008)
Crit Rev Oncol Hematol
, vol.66
, pp. 200-207
-
-
Lencioni, R.1
Crocetti, L.2
-
126
-
-
0035028475
-
Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma
-
PMID: 11343240
-
Llovet JM, Vilana R, Brú C, Bianchi L, Salmeron JM, Boix L, Ganau S, Sala M, Pagès M, Ayuso C, Solé M, Rodés J, Bruix J. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33: 1124-1129 [PMID: 11343240 DOI: 10.1053/jhep.2001.24233]
-
(2001)
Hepatology
, vol.33
, pp. 1124-1129
-
-
Llovet, J.M.1
Vilana, R.2
Brú, C.3
Bianchi, L.4
Salmeron, J.M.5
Boix, L.6
Ganau, S.7
Sala, M.8
Pagès, M.9
Ayuso, C.10
Solé, M.11
Rodés, J.12
Bruix, J.13
-
127
-
-
13844272488
-
Radiofrequency ablation of hepatocellular carcinoma: Treatment success as defined by histologic examination of the explanted liver
-
PMID: 15681691
-
Lu DS, Yu NC, Raman SS, Limanond P, Lassman C, Murray K, Tong MJ, Amado RG, Busuttil RW. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 2005; 234: 954-960 [PMID: 15681691 DOI: 10.1148/radiol.2343040153]
-
(2005)
Radiology
, vol.234
, pp. 954-960
-
-
Lu, D.S.1
Yu, N.C.2
Raman, S.S.3
Limanond, P.4
Lassman, C.5
Murray, K.6
Tong, M.J.7
Amado, R.G.8
Busuttil, R.W.9
-
128
-
-
0038714350
-
Small hepatocellular carcinoma in cirrhosis: Randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection
-
PMID: 12759473
-
Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, Frings H, Laubenberger J, Zuber I, Blum HE, Bartolozzi C. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228: 235-240 [PMID: 12759473 DOI: 10.1148/radiol.2281020718]
-
(2003)
Radiology
, vol.228
, pp. 235-240
-
-
Lencioni, R.A.1
Allgaier, H.P.2
Cioni, D.3
Olschewski, M.4
Deibert, P.5
Crocetti, L.6
Frings, H.7
Laubenberger, J.8
Zuber, I.9
Blum, H.E.10
Bartolozzi, C.11
-
129
-
-
9644265250
-
Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < Or =4 cm
-
PMID: 15578509
-
Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 2004; 127: 1714-1723 [PMID: 15578509]
-
(2004)
Gastroenterology
, vol.127
, pp. 1714-1723
-
-
Lin, S.M.1
Lin, C.J.2
Lin, C.C.3
Hsu, C.W.4
Chen, Y.C.5
-
130
-
-
22644441192
-
Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less
-
PMID: 16009687
-
Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005; 54: 1151-1156 [PMID: 16009687 DOI: 10.1136/gut.2004.045203]
-
(2005)
Gut
, vol.54
, pp. 1151-1156
-
-
Lin, S.M.1
Lin, C.J.2
Lin, C.C.3
Hsu, C.W.4
Chen, Y.C.5
-
131
-
-
45749093451
-
Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial
-
PMID: 18569991
-
Brunello F, Veltri A, Carucci P, Pagano E, Ciccone G, Moretto P, Sacchetto P, Gandini G, Rizzetto M. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial. Scand J Gastroenterol 2008; 43: 727-735 [PMID: 18569991 DOI: 10.1080/0036552070 1885481]
-
(2008)
Scand J Gastroenterol
, vol.43
, pp. 727-735
-
-
Brunello, F.1
Veltri, A.2
Carucci, P.3
Pagano, E.4
Ciccone, G.5
Moretto, P.6
Sacchetto, P.7
Gandini, G.8
Rizzetto, M.9
-
132
-
-
13844280344
-
Early-stage hepatocellular carcinoma in patients with cirrhosis: Long-term results of percutaneous image-guided radiofrequency ablation
-
PMID: 15665226
-
Lencioni R, Cioni D, Crocetti L, Franchini C, Pina CD, Lera J, Bartolozzi C. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234: 961-967 [PMID: 15665226 DOI: 10.1148/radiol.2343040350]
-
(2005)
Radiology
, vol.234
, pp. 961-967
-
-
Lencioni, R.1
Cioni, D.2
Crocetti, L.3
Franchini, C.4
Pina, C.D.5
Lera, J.6
Bartolozzi, C.7
-
133
-
-
78650130194
-
A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria
-
PMID: 21107100
-
Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, Xu Y, Zeng Y. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 2010; 252: 903-912 [PMID: 21107100 DOI: 10.1097/SLA.0b013e3181efc656]
-
(2010)
Ann Surg
, vol.252
, pp. 903-912
-
-
Huang, J.1
Yan, L.2
Cheng, Z.3
Wu, H.4
Du, L.5
Wang, J.6
Xu, Y.7
Zeng, Y.8
-
134
-
-
84880948632
-
Comparison of resection and ablation for hepatocellular carcinoma: A cohort study based on a Japanese nationwide survey
-
PMID: 23178708
-
Hasegawa K, Kokudo N, Makuuchi M, Izumi N, Ichida T, Kudo M, Ku Y, Sakamoto M, Nakashima O, Matsui O, Matsuyama Y. Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J Hepatol 2013; 58: 724-729 [PMID: 23178708 DOI: 10.1016/j.jhep.2012.11.009]
-
(2013)
J Hepatol
, vol.58
, pp. 724-729
-
-
Hasegawa, K.1
Kokudo, N.2
Makuuchi, M.3
Izumi, N.4
Ichida, T.5
Kudo, M.6
Ku, Y.7
Sakamoto, M.8
Nakashima, O.9
Matsui, O.10
Matsuyama, Y.11
-
135
-
-
38649141497
-
Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?
-
PMID: 18008357
-
Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, Rossi S. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 2008; 47: 82-89 [PMID: 18008357 DOI: 10.1002/hep.21933]
-
(2008)
Hepatology
, vol.47
, pp. 82-89
-
-
Livraghi, T.1
Meloni, F.2
Di Stasi, M.3
Rolle, E.4
Solbiati, L.5
Tinelli, C.6
Rossi, S.7
-
136
-
-
0036242424
-
Small hepatocellular carcinoma: Comparison of radio-frequency ablation and percutaneous microwave coagulation therapy
-
PMID: 11997534
-
Shibata T, Iimuro Y, Yamamoto Y, Maetani Y, Ametani F, Itoh K, Konishi J. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 2002; 223: 331-337 [PMID: 11997534 DOI: 10.1148/radiol.2232010775]
-
(2002)
Radiology
, vol.223
, pp. 331-337
-
-
Shibata, T.1
Iimuro, Y.2
Yamamoto, Y.3
Maetani, Y.4
Ametani, F.5
Itoh, K.6
Konishi, J.7
-
137
-
-
79953292241
-
Transarterial (chemo) embolisation for unresectable hepatocellular carcinoma
-
PMID: 21412886
-
Oliveri RS, Wetterslev J, Gluud C. Transarterial (chemo) embolisation for unresectable hepatocellular carcinoma. Cochrane Database Syst Rev 2011; (3): CD004787 [PMID: 21412886 DOI: 10.1002/14651858.CD004787.pub2]
-
(2011)
Cochrane Database Syst Rev
, Issue.3
, pp. CD004787
-
-
Oliveri, R.S.1
Wetterslev, J.2
Gluud, C.3
-
138
-
-
33749070991
-
Transarterial chemoembolisation for advanced hepatocellular carcinoma: Results from a North American cancer centre
-
PMID: 17100154
-
Molinari M, Kachura JR, Dixon E, Rajan DK, Hayeems EB, Asch MR, Benjamin MS, Sherman M, Gallinger S, Burnett B, Feld R, Chen E, Greig PD, Grant DR, Knox JJ. Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centre. Clin Oncol (R Coll Radiol) 2006; 18: 684-692 [PMID: 17100154]
-
(2006)
Clin Oncol (R Coll Radiol)
, vol.18
, pp. 684-692
-
-
Molinari, M.1
Kachura, J.R.2
Dixon, E.3
Rajan, D.K.4
Hayeems, E.B.5
Asch, M.R.6
Benjamin, M.S.7
Sherman, M.8
Gallinger, S.9
Burnett, B.10
Feld, R.11
Chen, E.12
Greig, P.D.13
Grant, D.R.14
Knox, J.J.15
-
139
-
-
0033972909
-
A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization
-
PMID: 10618605
-
Lladó L, Virgili J, Figueras J, Valls C, Dominguez J, Rafecas A, Torras J, Fabregat J, Guardiola J, Jaurrieta E. A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. Cancer 2000; 88: 50-57 [PMID: 10618605]
-
(2000)
Cancer
, vol.88
, pp. 50-57
-
-
Lladó, L.1
Virgili, J.2
Figueras, J.3
Valls, C.4
Dominguez, J.5
Rafecas, A.6
Torras, J.7
Fabregat, J.8
Guardiola, J.9
Jaurrieta, E.10
-
140
-
-
77949264899
-
Prospective randomized study of doxorubicineluting-bead embolization in the treatment of hepatocellular carcinoma: Results of the PRECISION v study
-
PMID: 19908093
-
Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, Pitton M, Sergent G, Pfammatter T, Terraz S, Benhamou Y, Avajon Y, Gruenberger T, Pomoni M, Langenberger H, Schuchmann M, Dumortier J, Mueller C, Chevallier P, Lencioni R. Prospective randomized study of doxorubicineluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 2010; 33: 41-52 [PMID: 19908093 DOI: 10.1007/s00270-009-9711-7]
-
(2010)
Cardiovasc Intervent Radiol
, vol.33
, pp. 41-52
-
-
Lammer, J.1
Malagari, K.2
Vogl, T.3
Pilleul, F.4
Denys, A.5
Watkinson, A.6
Pitton, M.7
Sergent, G.8
Pfammatter, T.9
Terraz, S.10
Benhamou, Y.11
Avajon, Y.12
Gruenberger, T.13
Pomoni, M.14
Langenberger, H.15
Schuchmann, M.16
Dumortier, J.17
Mueller, C.18
Chevallier, P.19
Lencioni, R.20
more..
-
141
-
-
0023857307
-
Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma - A randomized controlled trial
-
PMID: 2826285
-
Lin DY, Liaw YF, Lee TY, Lai CM. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma-a randomized controlled trial. Gastroenterology 1988; 94: 453-456 [PMID: 2826285]
-
(1988)
Gastroenterology
, vol.94
, pp. 453-456
-
-
Lin, D.Y.1
Liaw, Y.F.2
Lee, T.Y.3
Lai, C.M.4
-
142
-
-
0025242359
-
A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma
-
PMID: 2174933
-
Pelletier G, Roche A, Ink O, Anciaux ML, Derhy S, Rougier P, Lenoir C, Attali P, Etienne JP. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 1990; 11: 181-184 [PMID: 2174933]
-
(1990)
J Hepatol
, vol.11
, pp. 181-184
-
-
Pelletier, G.1
Roche, A.2
Ink, O.3
Anciaux, M.L.4
Derhy, S.5
Rougier, P.6
Lenoir, C.7
Attali, P.8
Etienne, J.P.9
-
143
-
-
0031801297
-
Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution
-
PMID: 9620330
-
Bruix J, Llovet JM, Castells A, Montañá X, Brú C, Ayuso MC, Vilana R, Rodés J. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 1998; 27: 1578-1583 [PMID: 9620330 DOI: 10.1002/hep.510270617]
-
(1998)
Hepatology
, vol.27
, pp. 1578-1583
-
-
Bruix, J.1
Llovet, J.M.2
Castells, A.3
Montañá, X.4
Brú, C.5
Ayuso, M.C.6
Vilana, R.7
Rodés, J.8
-
144
-
-
76649124246
-
Transarterial chemoembolization with epirubicineluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma
-
PMID: 20097098
-
Nicolini A, Martinetti L, Crespi S, Maggioni M, Sangiovanni A. Transarterial chemoembolization with epirubicineluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma. J Vasc Interv Radiol 2010; 21: 327-332 [PMID: 20097098 DOI: 10.1016/j.jvir.2009.10.038]
-
(2010)
J Vasc Interv Radiol
, vol.21
, pp. 327-332
-
-
Nicolini, A.1
Martinetti, L.2
Crespi, S.3
Maggioni, M.4
Sangiovanni, A.5
-
145
-
-
77956494929
-
Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer
-
PMID: 20813065
-
Kwon JH, Bae SH, Kim JY, Choi BO, Jang HS, Jang JW, Choi JY, Yoon SK, Chung KW. Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer. BMC Cancer 2010; 10: 475 [PMID: 20813065 DOI: 10.1186/1471-2407-10-475]
-
(2010)
BMC Cancer
, vol.10
, pp. 475
-
-
Kwon, J.H.1
Bae, S.H.2
Kim, J.Y.3
Choi, B.O.4
Jang, H.S.5
Jang, J.W.6
Choi, J.Y.7
Yoon, S.K.8
Chung, K.W.9
-
146
-
-
80255123361
-
Stereotactic body radiotherapy for primary hepatocellular carcinoma
-
PMID: 21645977
-
Andolino DL, Johnson CS, Maluccio M, Kwo P, Tector AJ, Zook J, Johnstone PA, Cardenes HR. Stereotactic body radiotherapy for primary hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2011; 81: e447-e453 [PMID: 21645977 DOI: 10.1016/j.ijrobp.2011.04.011]
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.81
, pp. e447-e453
-
-
Andolino, D.L.1
Johnson, C.S.2
Maluccio, M.3
Kwo, P.4
Tector, A.J.5
Zook, J.6
Johnstone, P.A.7
Cardenes, H.R.8
-
147
-
-
84865663687
-
Stereotactic body radiation therapy in recurrent hepatocellular carcinoma
-
PMID: 22342300
-
Huang WY, Jen YM, Lee MS, Chang LP, Chen CM, Ko KH, Lin KT, Lin JC, Chao HL, Lin CS, Su YF, Fan CY, Chang YW. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2012; 84: 355-361 [PMID: 22342300 DOI: 10.1016/j.ijrobp.2011.11.058]
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.84
, pp. 355-361
-
-
Huang, W.Y.1
Jen, Y.M.2
Lee, M.S.3
Chang, L.P.4
Chen, C.M.5
Ko, K.H.6
Lin, K.T.7
Lin, J.C.8
Chao, H.L.9
Lin, C.S.10
Su, Y.F.11
Fan, C.Y.12
Chang, Y.W.13
-
148
-
-
84867864780
-
Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization
-
PMID: 22570179
-
Kang JK, Kim MS, Cho CK, Yang KM, Yoo HJ, Kim JH, Bae SH, Jung da H, Kim KB, Lee DH, Han CJ, Kim J, Park SC, Kim YH. Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization. Cancer 2012; 118: 5424-5431 [PMID: 22570179 DOI: 10.1002/cncr.27533]
-
(2012)
Cancer
, vol.118
, pp. 5424-5431
-
-
Kang, J.K.1
Kim, M.S.2
Cho, C.K.3
Yang, K.M.4
Yoo, H.J.5
Kim, J.H.6
Bae, S.H.7
Jung Da, H.8
Kim, K.B.9
Lee, D.H.10
Han, C.J.11
Kim, J.12
Park, S.C.13
Kim, Y.H.14
-
149
-
-
84859920492
-
Stereotactic body radiation therapy in hepatocellular carcinoma and cirrhosis: Evaluation of radiological and pathological response
-
PMID: 21960321
-
Facciuto ME, Singh MK, Rochon C, Sharma J, Gimenez C, Katta U, Moorthy CR, Bentley-Hibbert S, Rodriguez-Davalos M, Wolf DC. Stereotactic body radiation therapy in hepatocellular carcinoma and cirrhosis: evaluation of radiological and pathological response. J Surg Oncol 2012; 105: 692-698 [PMID: 21960321 DOI: 10.1002/jso.22104]
-
(2012)
J Surg Oncol
, vol.105
, pp. 692-698
-
-
Facciuto, M.E.1
Singh, M.K.2
Rochon, C.3
Sharma, J.4
Gimenez, C.5
Katta, U.6
Moorthy, C.R.7
Bentley-Hibbert, S.8
Rodriguez-Davalos, M.9
Wolf, D.C.10
-
150
-
-
33748927955
-
Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma
-
PMID: 16904840
-
Sangro B, Bilbao JI, Boan J, Martinez-Cuesta A, Benito A, Rodriguez J, Panizo A, Gil B, Inarrairaegui M, Herrero I, Quiroga J, Prieto J. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2006; 66: 792-800 [PMID: 16904840 DOI: 10.1016/j.ijrobp.2006.05.065]
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.66
, pp. 792-800
-
-
Sangro, B.1
Bilbao, J.I.2
Boan, J.3
Martinez-Cuesta, A.4
Benito, A.5
Rodriguez, J.6
Panizo, A.7
Gil, B.8
Inarrairaegui, M.9
Herrero, I.10
Quiroga, J.11
Prieto, J.12
-
151
-
-
38649127852
-
Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis
-
PMID: 18027884
-
Kulik LM, Carr BI, Mulcahy MF, Lewandowski RJ, Atassi B, Ryu RK, Sato KT, Benson A, Nemcek AA, Gates VL, Abecassis M, Omary RA, Salem R. Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology 2008; 47: 71-81 [PMID: 18027884 DOI: 10.1002/hep.21980]
-
(2008)
Hepatology
, vol.47
, pp. 71-81
-
-
Kulik, L.M.1
Carr, B.I.2
Mulcahy, M.F.3
Lewandowski, R.J.4
Atassi, B.5
Ryu, R.K.6
Sato, K.T.7
Benson, A.8
Nemcek, A.A.9
Gates, V.L.10
Abecassis, M.11
Omary, R.A.12
Salem, R.13
-
152
-
-
78049487253
-
Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival
-
PMID: 21038413
-
Hilgard P, Hamami M, Fouly AE, Scherag A, Müller S, Ertle J, Heusner T, Cicinnati VR, Paul A, Bockisch A, Gerken G, Antoch G. Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. Hepatology 2010; 52: 1741-1749 [PMID: 21038413 DOI: 10.1002/hep.23944]
-
(2010)
Hepatology
, vol.52
, pp. 1741-1749
-
-
Hilgard, P.1
Hamami, M.2
Fouly, A.E.3
Scherag, A.4
Müller, S.5
Ertle, J.6
Heusner, T.7
Cicinnati, V.R.8
Paul, A.9
Bockisch, A.10
Gerken, G.11
Antoch, G.12
-
153
-
-
72249087123
-
Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: A comprehensive report of long-term outcomes
-
PMID: 19766639
-
Salem R, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Ibrahim S, Atassi B, Baker T, Gates V, Miller FH, Sato KT, Wang E, Gupta R, Benson AB, Newman SB, Omary RA, Abecassis M, Kulik L. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology 2010; 138: 52-64 [PMID: 19766639 DOI: 10.1053/j.gastro.2009.09.006]
-
(2010)
Gastroenterology
, vol.138
, pp. 52-64
-
-
Salem, R.1
Lewandowski, R.J.2
Mulcahy, M.F.3
Riaz, A.4
Ryu, R.K.5
Ibrahim, S.6
Atassi, B.7
Baker, T.8
Gates, V.9
Miller, F.H.10
Sato, K.T.11
Wang, E.12
Gupta, R.13
Benson, A.B.14
Newman, S.B.15
Omary, R.A.16
Abecassis, M.17
Kulik, L.18
-
154
-
-
65349096880
-
Selection of patients with hepatocellular carcinoma for sorafenib
-
PMID: 19406040
-
Abou-Alfa GK. Selection of patients with hepatocellular carcinoma for sorafenib. J Natl Compr Canc Netw 2009; 7: 397-403 [PMID: 19406040]
-
(2009)
J Natl Compr Canc Netw
, vol.7
, pp. 397-403
-
-
Abou-Alfa, G.K.1
-
155
-
-
80053041858
-
Safety and efficacy of sorafenib in patients with hepatocellular carcinoma (HCC) and child-pugh a versus b cirrhosis
-
PMID: 21673874
-
Abou-Alfa GK, Amadori D, Santoro A, Figer A, De Greve J, Lathia C, Voliotis D, Anderson S, Moscovici M, Ricci S. Safety and Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma (HCC) and Child-Pugh A versus B Cirrhosis. Gastrointest Cancer Res 2011; 4: 40-44 [PMID: 21673874]
-
(2011)
Gastrointest Cancer Res
, vol.4
, pp. 40-44
-
-
Abou-Alfa, G.K.1
Amadori, D.2
Santoro, A.3
Figer, A.4
De Greve, J.5
Lathia, C.6
Voliotis, D.7
Anderson, S.8
Moscovici, M.9
Ricci, S.10
-
156
-
-
80055017402
-
Safety and efficacy of sorafenib in hepatocellular carcinoma: The impact of the Child-Pugh score
-
PMID: 21958438
-
Hollebecque A, Cattan S, Romano O, Sergent G, Mourad A, Louvet A, Dharancy S, Boleslawski E, Truant S, Pruvot FR, Hebbar M, Ernst O, Mathurin P. Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child-Pugh score. Aliment Pharmacol Ther 2011; 34: 1193-1201 [PMID: 21958438 DOI: 10.1111/j.1365-2036.2011.04860.x]
-
(2011)
Aliment Pharmacol Ther
, vol.34
, pp. 1193-1201
-
-
Hollebecque, A.1
Cattan, S.2
Romano, O.3
Sergent, G.4
Mourad, A.5
Louvet, A.6
Dharancy, S.7
Boleslawski, E.8
Truant, S.9
Pruvot, F.R.10
Hebbar, M.11
Ernst, O.12
Mathurin, P.13
-
157
-
-
82455192245
-
Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function
-
PMID: 21445543
-
Kim JE, Ryoo BY, Ryu MH, Chang HM, Suh DJ, Lee HC, Lim YS, Kim KM, Kang YK. Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function. Cancer Chemother Pharmacol 2011; 68: 1285-1290 [PMID: 21445543 DOI: 10.1007/s00280-011-1616-x]
-
(2011)
Cancer Chemother Pharmacol
, vol.68
, pp. 1285-1290
-
-
Kim, J.E.1
Ryoo, B.Y.2
Ryu, M.H.3
Chang, H.M.4
Suh, D.J.5
Lee, H.C.6
Lim, Y.S.7
Kim, K.M.8
Kang, Y.K.9
-
158
-
-
84984559340
-
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma
-
PMID: 22833179
-
Toh HC, Chen PJ, Carr BI, Knox JJ, Gill S, Ansell P, McKeegan EM, Dowell B, Pedersen M, Qin Q, Qian J, Scappaticci FA, Ricker JL, Carlson DM, Yong WP. Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma. Cancer 2013; 119: 380-387 [PMID: 22833179 DOI: 10.1002/cncr.27758]
-
(2013)
Cancer
, vol.119
, pp. 380-387
-
-
Toh, H.C.1
Chen, P.J.2
Carr, B.I.3
Knox, J.J.4
Gill, S.5
Ansell, P.6
McKeegan, E.M.7
Dowell, B.8
Pedersen, M.9
Qin, Q.10
Qian, J.11
Scappaticci, F.A.12
Ricker, J.L.13
Carlson, D.M.14
Yong, W.P.15
-
159
-
-
77953124105
-
Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma
-
PMID: 20416968
-
Hsu CH, Shen YC, Lin ZZ, Chen PJ, Shao YY, Ding YH, Hsu C, Cheng AL. Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma. J Hepatol 2010; 53: 126-131 [PMID: 20416968 DOI: 10.1016/j.jhep.2010.01.035]
-
(2010)
J Hepatol
, vol.53
, pp. 126-131
-
-
Hsu, C.H.1
Shen, Y.C.2
Lin, Z.Z.3
Chen, P.J.4
Shao, Y.Y.5
Ding, Y.H.6
Hsu, C.7
Cheng, A.L.8
-
160
-
-
34548150925
-
Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma
-
PMID: 17623837
-
Thomas MB, Chadha R, Glover K, Wang X, Morris J, Brown T, Rashid A, Dancey J, Abbruzzese JL. Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma. Cancer 2007; 110: 1059-1067 [PMID: 17623837 DOI: 10.1002/cncr.22886]
-
(2007)
Cancer
, vol.110
, pp. 1059-1067
-
-
Thomas, M.B.1
Chadha, R.2
Glover, K.3
Wang, X.4
Morris, J.5
Brown, T.6
Rashid, A.7
Dancey, J.8
Abbruzzese, J.L.9
-
161
-
-
60849124241
-
Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma
-
PMID: 19139433
-
Thomas MB, Morris JS, Chadha R, Iwasaki M, Kaur H, Lin E, Kaseb A, Glover K, Davila M, Abbruzzese J. Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma. J Clin Oncol 2009; 27: 843-850 [PMID: 19139433 DOI: 10.1200/JCO.2008.18.3301]
-
(2009)
J Clin Oncol
, vol.27
, pp. 843-850
-
-
Thomas, M.B.1
Morris, J.S.2
Chadha, R.3
Iwasaki, M.4
Kaur, H.5
Lin, E.6
Kaseb, A.7
Glover, K.8
Davila, M.9
Abbruzzese, J.10
-
162
-
-
67651165187
-
Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: An open-label, multicentre, phase II study
-
PMID: 19586800
-
Faivre S, Raymond E, Boucher E, Douillard J, Lim HY, Kim JS, Zappa M, Lanzalone S, Lin X, Deprimo S, Harmon C, Ruiz-Garcia A, Lechuga MJ, Cheng AL. Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study. Lancet Oncol 2009; 10: 794-800 [PMID: 19586800 DOI: 10.1016/S1470-2045(09)70171-8]
-
(2009)
Lancet Oncol
, vol.10
, pp. 794-800
-
-
Faivre, S.1
Raymond, E.2
Boucher, E.3
Douillard, J.4
Lim, H.Y.5
Kim, J.S.6
Zappa, M.7
Lanzalone, S.8
Lin, X.9
Deprimo, S.10
Harmon, C.11
Ruiz-Garcia, A.12
Lechuga, M.J.13
Cheng, A.L.14
-
163
-
-
79955433548
-
Targeted therapies for hepatocellular carcinoma
-
PMID: 21406195
-
Villanueva A, Llovet JM. Targeted therapies for hepatocellular carcinoma. Gastroenterology 2011; 140: 1410-1426 [PMID: 21406195 DOI: 10.1053/j.gastro.2011.03.006]
-
(2011)
Gastroenterology
, vol.140
, pp. 1410-1426
-
-
Villanueva, A.1
Llovet, J.M.2
|